used chimeric antigen receptor therapy with CAR-transduced T and NK cells that recognize the surface marker CD147 to effectively kill various malignant HCC cell lines in vitro, as well as HCC tumors in xenograft and patient-derived xenograft mouse models. The gene discussed is BSG; the disease is hepatocellular carcinoma.